25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Antibiotice Ia
Buy, Hold or Sell?

Let's analyze Antibiotice together

I guess you are interested in Antibiotice Ia. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Antibiotice Ia. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Antibiotice Ia

I send you an email if I find something interesting about Antibiotice Ia.

1. Quick Overview

1.1. Quick analysis of Antibiotice (30 sec.)










1.2. What can you expect buying and holding a share of Antibiotice? (30 sec.)

How much money do you get?

How much money do you get?
L0.01
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
L1.31
Expected worth in 1 year
L1.54
How sure are you?
85.7%

+ What do you gain per year?

Total Gains per Share
L0.27
Return On Investment
10.9%

For what price can you sell your share?

Current Price per Share
L2.53
Expected price per share
L2.32 - L2.6
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Antibiotice (5 min.)




Live pricePrice per Share (EOD)
L2.53

2.2. Growth of Antibiotice (5 min.)




Is Antibiotice growing?

Current yearPrevious yearGrowGrow %
How rich?$184.3m$146.7m$35.4m19.5%

How much money is Antibiotice making?

Current yearPrevious yearGrowGrow %
Making money$4.8m$5.3m-$525.2k-10.9%
Net Profit Margin13.6%17.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Antibiotice (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Antibiotice?

Welcome investor! Antibiotice's management wants to use your money to grow the business. In return you get a share of Antibiotice.

First you should know what it really means to hold a share of Antibiotice. And how you can make/lose money.

Speculation

The Price per Share of Antibiotice is L2.53. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Antibiotice.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Antibiotice, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is L1.31. Based on the TTM, the Book Value Change Per Share is L0.06 per quarter. Based on the YOY, the Book Value Change Per Share is L0.36 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is L0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Antibiotice.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 L% of Price per ShareL% of Price per ShareL% of Price per ShareL% of Price per ShareL% of Price per Share
Usd Eps0.000.2%0.010.3%0.010.3%0.010.3%0.010.3%
Usd Book Value Change Per Share0.000.2%0.010.5%0.083.0%0.041.6%0.041.6%
Usd Dividend Per Share0.010.4%0.000.1%0.000.0%0.000.1%0.000.1%
Usd Total Gains Per Share0.010.5%0.010.6%0.083.0%0.041.6%0.041.6%
Usd Price Per Share0.69-0.49-0.17-0.35-0.35-
Price to Earnings Ratio40.42-28.85-6.87-19.43-19.43-
Price-to-Total Gains Ratio51.36--6.23-16.69-3.59-3.59-
Price to Book Ratio2.53-1.81-0.77-1.36-1.36-
Price-to-Total Gains Ratio51.36--6.23-16.69-3.59-3.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.530541
Number of shares1884
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.04
Usd Total Gains Per Share0.010.04
Gains per Quarter (1884 shares)27.1476.99
Gains per Year (1884 shares)108.58307.96
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
120899912296298
23917820825591606
35926731737887914
4783564264911831222
5984455356114781530
61175346447417741838
71376237538620702146
81567128629823652454
917680197111126612762
10195890108012329573070

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%6.01.00.085.7%6.01.00.085.7%6.01.00.085.7%6.01.00.085.7%
Dividend per Share4.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share3.01.00.075.0%6.01.00.085.7%6.01.00.085.7%6.01.00.085.7%6.01.00.085.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Antibiotice Ia compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0200.056-64%0.361-94%0.187-89%0.187-89%
Book Value Per Share--1.3101.294+1%1.042+26%1.186+10%1.186+10%
Current Ratio--2.2472.191+3%2.320-3%2.246+0%2.246+0%
Debt To Asset Ratio--0.2920.278+5%0.260+12%0.270+8%0.270+8%
Debt To Equity Ratio--0.4120.386+7%0.352+17%0.371+11%0.371+11%
Dividend Per Share--0.0440.012+256%0.002+2534%0.008+465%0.008+465%
Enterprise Value--1860162214.4001239431816.100+50%300370203.200+519%836976839.143+122%836976839.143+122%
Eps--0.0200.034-40%0.038-46%0.036-43%0.036-43%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--2.9961.929+55%0.507+491%1.319+127%1.319+127%
Free Cash Flow Per Share--0.0260.016+57%0.004+526%0.011+131%0.011+131%
Free Cash Flow To Equity Per Share--0.0260.016+57%0.004+526%0.011+131%0.011+131%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap1698485099.520-31%2222128912.4001575126876.350+41%546021605.867+307%1134081760.429+96%1134081760.429+96%
Net Profit Margin--0.0890.136-35%0.172-48%0.151-41%0.151-41%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.3401.199+12%1.090+23%1.152+16%1.152+16%
Pb Ratio1.932-31%2.5271.809+40%0.773+227%1.365+85%1.365+85%
Pe Ratio30.898-31%40.42428.848+40%6.870+488%19.429+108%19.429+108%
Price Per Share2.530-31%3.3102.346+41%0.813+307%1.689+96%1.689+96%
Price To Free Cash Flow Ratio24.782-31%32.42211.099+192%8.134+299%9.828+230%9.828+230%
Price To Total Gains Ratio39.260-31%51.363-6.230+112%16.686+208%3.591+1330%3.591+1330%
Quick Ratio--1.3921.328+5%1.521-8%1.411-1%1.411-1%
Return On Assets--0.0110.019-42%0.027-59%0.022-51%0.022-51%
Return On Equity--0.0160.026-41%0.037-57%0.031-49%0.031-49%
Total Gains Per Share--0.0640.069-6%0.363-82%0.195-67%0.195-67%
Usd Book Value--184375454.099182227530.499+1%146751242.687+26%167023407.151+10%167023407.151+10%
Usd Book Value Change Per Share--0.0040.012-64%0.076-94%0.039-89%0.039-89%
Usd Book Value Per Share--0.2750.271+1%0.219+26%0.249+10%0.249+10%
Usd Dividend Per Share--0.0090.003+256%0.000+2534%0.002+465%0.002+465%
Usd Enterprise Value--390076016.360259908851.836+50%62987631.611+519%175514043.168+122%175514043.168+122%
Usd Eps--0.0040.007-40%0.008-46%0.008-43%0.008-43%
Usd Free Cash Flow--3593113.2482293307.981+57%573858.449+526%1556401.039+131%1556401.039+131%
Usd Free Cash Flow Per Share--0.0050.003+57%0.001+526%0.002+131%0.002+131%
Usd Free Cash Flow To Equity Per Share--0.0050.003+57%0.001+526%0.002+131%0.002+131%
Usd Market Cap356172325.369-31%465980432.930330304105.971+41%114500730.750+307%237816945.162+96%237816945.162+96%
Usd Price Per Share0.531-31%0.6940.492+41%0.171+307%0.354+96%0.354+96%
Usd Profit--2881801.8314838386.658-40%5363673.957-46%5063509.786-43%5063509.786-43%
Usd Revenue--32545849.33433730321.750-4%32393853.881+0%33157549.806-2%33157549.806-2%
Usd Total Gains Per Share--0.0140.014-6%0.076-82%0.041-67%0.041-67%
 EOD+4 -4MRQTTM+19 -18YOY+18 -195Y+18 -1910Y+18 -19

3.3 Fundamental Score

Let's check the fundamental score of Antibiotice Ia based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1530.898
Price to Book Ratio (EOD)Between0-11.932
Net Profit Margin (MRQ)Greater than00.089
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.392
Current Ratio (MRQ)Greater than12.247
Debt to Asset Ratio (MRQ)Less than10.292
Debt to Equity Ratio (MRQ)Less than10.412
Return on Equity (MRQ)Greater than0.150.016
Return on Assets (MRQ)Greater than0.050.011
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Antibiotice Ia based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.790
Ma 20Greater thanMa 502.573
Ma 50Greater thanMa 1002.728
Ma 100Greater thanMa 2002.905
OpenGreater thanClose2.560
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Antibiotice Ia

Antibiotice S.A. produces and sells medicinal products in Romania. The company produces medicines for a range of therapeutic areas, such as cardiovascular system, alimentary tract and metabolism, musculo-skeletal system, nervous system, antiinfectives, respiratory system, dermatological, food supplements, sensory organs, genito-urinary apparatus and sexual hormones, varia, and blood and blood forming organs, as well as veterinary medicinal products. It offers its products in the form of sterile injectable powders, capsules, tablets, ointments, gels, creams, and suppositories. The company also provides active pharmaceutical ingredient. In addition, it exports its products worldwide. The company was founded in 1955 and is headquartered in Iasi, Romania.

Fundamental data was last updated by Penke on 2025-01-24 15:34:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Antibiotice earns for each lei1 of revenue.

  • Above 10% is considered healthy but always compare Antibiotice to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 8.9% means that lei0.09 for each lei1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Antibiotice Ia:

  • The MRQ is 8.9%. The company is making a profit. +1
  • The TTM is 13.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ8.9%TTM13.6%-4.7%
TTM13.6%YOY17.2%-3.6%
TTM13.6%5Y15.1%-1.5%
5Y15.1%10Y15.1%0.0%
4.3.1.2. Return on Assets

Shows how efficient Antibiotice is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Antibiotice to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.1% Return on Assets means that Antibiotice generated lei0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Antibiotice Ia:

  • The MRQ is 1.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.1%TTM1.9%-0.8%
TTM1.9%YOY2.7%-0.8%
TTM1.9%5Y2.2%-0.3%
5Y2.2%10Y2.2%0.0%
4.3.1.3. Return on Equity

Shows how efficient Antibiotice is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Antibiotice to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.6% Return on Equity means Antibiotice generated lei0.02 for each lei1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Antibiotice Ia:

  • The MRQ is 1.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.6%TTM2.6%-1.1%
TTM2.6%YOY3.7%-1.0%
TTM2.6%5Y3.1%-0.4%
5Y3.1%10Y3.1%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Antibiotice Ia.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Antibiotice is operating .

  • Measures how much profit Antibiotice makes for each lei1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Antibiotice to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated lei0.00  for each lei1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Antibiotice Ia:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Antibiotice is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.34 means that the operating costs are lei1.34 for each lei1 in net sales.

Let's take a look of the Operating Ratio trends of Antibiotice Ia:

  • The MRQ is 1.340. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.199. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.340TTM1.199+0.141
TTM1.199YOY1.090+0.108
TTM1.1995Y1.152+0.046
5Y1.15210Y1.1520.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Antibiotice Ia.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Antibiotice is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.25 means the company has lei2.25 in assets for each lei1 in short-term debts.

Let's take a look of the Current Ratio trends of Antibiotice Ia:

  • The MRQ is 2.247. The company is able to pay all its short-term debts. +1
  • The TTM is 2.191. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.247TTM2.191+0.056
TTM2.191YOY2.320-0.129
TTM2.1915Y2.246-0.055
5Y2.24610Y2.2460.000
4.4.3.2. Quick Ratio

Measures if Antibiotice is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Antibiotice to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.39 means the company can pay off lei1.39 for each lei1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Antibiotice Ia:

  • The MRQ is 1.392. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.328. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.392TTM1.328+0.064
TTM1.328YOY1.521-0.193
TTM1.3285Y1.411-0.083
5Y1.41110Y1.4110.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Antibiotice Ia.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Antibiotice assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Antibiotice to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.29 means that Antibiotice assets are financed with 29.2% credit (debt) and the remaining percentage (100% - 29.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Antibiotice Ia:

  • The MRQ is 0.292. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.278. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.292TTM0.278+0.014
TTM0.278YOY0.260+0.018
TTM0.2785Y0.270+0.008
5Y0.27010Y0.2700.000
4.5.4.2. Debt to Equity Ratio

Measures if Antibiotice is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Antibiotice to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 41.2% means that company has lei0.41 debt for each lei1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Antibiotice Ia:

  • The MRQ is 0.412. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.386. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.412TTM0.386+0.025
TTM0.386YOY0.352+0.035
TTM0.3865Y0.371+0.015
5Y0.37110Y0.3710.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every lei1 in earnings Antibiotice generates.

  • Above 15 is considered overpriced but always compare Antibiotice to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 40.42 means the investor is paying lei40.42 for every lei1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Antibiotice Ia:

  • The EOD is 30.898. Based on the earnings, the company is overpriced. -1
  • The MRQ is 40.424. Based on the earnings, the company is overpriced. -1
  • The TTM is 28.848. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD30.898MRQ40.424-9.526
MRQ40.424TTM28.848+11.577
TTM28.848YOY6.870+21.978
TTM28.8485Y19.429+9.419
5Y19.42910Y19.4290.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Antibiotice Ia:

  • The EOD is 24.782. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 32.422. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 11.099. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD24.782MRQ32.422-7.640
MRQ32.422TTM11.099+21.323
TTM11.099YOY8.134+2.964
TTM11.0995Y9.828+1.270
5Y9.82810Y9.8280.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Antibiotice is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.53 means the investor is paying lei2.53 for each lei1 in book value.

Let's take a look of the Price to Book Ratio trends of Antibiotice Ia:

  • The EOD is 1.932. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.527. Based on the equity, the company is underpriced. +1
  • The TTM is 1.809. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.932MRQ2.527-0.596
MRQ2.527TTM1.809+0.719
TTM1.809YOY0.773+1.036
TTM1.8095Y1.365+0.444
5Y1.36510Y1.3650.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in RON. All numbers in thousands.

Summary
Total Assets1,241,201
Total Liabilities361,967
Total Stockholder Equity879,234
 As reported
Total Liabilities 361,967
Total Stockholder Equity+ 879,234
Total Assets = 1,241,201

Assets

Total Assets1,241,201
Total Current Assets462,399
Long-term Assets778,802
Total Current Assets
Cash And Cash Equivalents 28,907
Net Receivables 286,522
Inventory 156,910
Total Current Assets  (as reported)462,399
Total Current Assets  (calculated)472,338
+/- 9,939
Long-term Assets
Property Plant Equipment 729,369
Intangible Assets 49,433
Long-term Assets  (as reported)778,802
Long-term Assets  (calculated)778,802
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities205,817
Long-term Liabilities156,149
Total Stockholder Equity879,234
Total Current Liabilities
Short Long Term Debt 33,322
Accounts payable 66,298
Total Current Liabilities  (as reported)205,817
Total Current Liabilities  (calculated)99,620
+/- 106,197
Long-term Liabilities
Long term Debt 88,393
Long-term Liabilities  (as reported)156,149
Long-term Liabilities  (calculated)88,393
+/- 67,756
Total Stockholder Equity
Retained Earnings 261,608
Total Stockholder Equity (as reported)879,234
Total Stockholder Equity (calculated)261,608
+/- 617,627
Other
Capital Stock67,134
Common Stock Shares Outstanding 671,338
Net Debt 92,808
Net Invested Capital 1,000,949
Net Working Capital 256,582
Property Plant and Equipment Gross 916,662



6.2. Balance Sheets Structured

Currency in RON. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-30
> Total Assets 
0
0
914,037
953,345
969,018
1,139,172
1,173,385
1,264,988
1,241,201
1,241,2011,264,9881,173,3851,139,172969,018953,345914,03700
   > Total Current Assets 
0
0
375,873
407,021
405,917
401,284
433,443
512,269
462,399
462,399512,269433,443401,284405,917407,021375,87300
       Cash And Cash Equivalents 
0
0
744
369
3,166
1,808
355
60,755
28,907
28,90760,7553551,8083,16636974400
       Net Receivables 
0
0
254,598
263,615
261,387
235,772
278,014
293,360
286,522
286,522293,360278,014235,772261,387263,615254,59800
   > Long-term Assets 
0
0
538,164
546,324
563,101
737,888
739,941
752,719
778,802
778,802752,719739,941737,888563,101546,324538,16400
       Property Plant Equipment 
0
0
499,192
504,261
518,153
692,362
696,004
706,655
729,369
729,369706,655696,004692,362518,153504,261499,19200
       Intangible Assets 
0
0
38,973
42,063
44,947
45,527
43,937
46,064
49,433
49,43346,06443,93745,52744,94742,06338,97300
> Total Liabilities 
0
0
250,403
245,453
241,098
292,208
289,106
399,500
361,967
361,967399,500289,106292,208241,098245,453250,40300
   > Total Current Liabilities 
0
0
174,152
170,087
168,495
190,470
190,412
240,155
205,817
205,817240,155190,412190,470168,495170,087174,15200
       Short Long Term Debt 
0
0
48,948
41,861
38,205
29,552
43,291
27,329
33,322
33,32227,32943,29129,55238,20541,86148,94800
       Accounts payable 
0
0
76,362
68,874
68,124
76,540
86,032
80,139
66,298
66,29880,13986,03276,54068,12468,87476,36200
       Other Current Liabilities 
99
1,117
1,134
1,135
1,136
140
143
158
0
01581431401,1361,1351,1341,11799
   > Long-term Liabilities 
0
0
76,251
75,366
72,602
101,738
98,694
159,344
156,149
156,149159,34498,694101,73872,60275,36676,25100
> Total Stockholder Equity
0
0
663,634
707,891
727,920
846,964
884,279
865,489
879,234
879,234865,489884,279846,964727,920707,891663,63400
   Common Stock000000000
   Retained Earnings Total Equity000000000
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 000000000



6.3. Balance Sheets

Currency in RON. All numbers in thousands.




6.4. Cash Flows

Currency in RON. All numbers in thousands.




6.5. Income Statements

Currency in RON. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-09-30. Currency in RON. All numbers in thousands.

Gross Profit (+$)
totalRevenue600,781
Cost of Revenue-191,378
Gross Profit409,403409,403
 
Operating Income (+$)
Gross Profit409,403
Operating Expense-503,822
Operating Income96,959-94,419
 
Operating Expense (+$)
Research Development0
Selling General Administrative31,637
Selling And Marketing Expenses0
Operating Expense503,82231,637
 
Net Interest Income (+$)
Interest Income4
Interest Expense-4,146
Other Finance Cost-77
Net Interest Income-4,064
 
Pretax Income (+$)
Operating Income96,959
Net Interest Income-4,064
Other Non-Operating Income Expenses0
Income Before Tax (EBT)91,52496,959
EBIT - interestExpense = -4,146
81,089
85,234
Interest Expense4,146
Earnings Before Interest and Taxes (EBIT)095,670
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax91,524
Tax Provision-10,436
Net Income From Continuing Ops81,08981,089
Net Income81,089
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net04,064
 

Technical Analysis of Antibiotice
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Antibiotice. The general trend of Antibiotice is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Antibiotice's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Antibiotice Ia.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.54 < 2.54 < 2.6.

The bearish price targets are: 2.41 > 2.3950706319703 > 2.32.

Tweet this
Antibiotice Ia Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Antibiotice Ia. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Antibiotice Ia Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Antibiotice Ia. The current macd is -0.04062187.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Antibiotice price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Antibiotice. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Antibiotice price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Antibiotice Ia Daily Moving Average Convergence/Divergence (MACD) ChartAntibiotice Ia Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Antibiotice Ia. The current adx is 38.60.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Antibiotice shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Antibiotice Ia Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Antibiotice Ia. The current sar is 2.48322966.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Antibiotice Ia Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Antibiotice Ia. The current rsi is 39.79. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Antibiotice Ia Daily Relative Strength Index (RSI) ChartAntibiotice Ia Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Antibiotice Ia. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Antibiotice price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Antibiotice Ia Daily Stochastic Oscillator ChartAntibiotice Ia Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Antibiotice Ia. The current cci is -131.16970926.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Antibiotice Ia Daily Commodity Channel Index (CCI) ChartAntibiotice Ia Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Antibiotice Ia. The current cmo is -22.96713729.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Antibiotice Ia Daily Chande Momentum Oscillator (CMO) ChartAntibiotice Ia Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Antibiotice Ia. The current willr is -77.77777778.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Antibiotice is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Antibiotice Ia Daily Williams %R ChartAntibiotice Ia Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Antibiotice Ia.

Antibiotice Ia Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Antibiotice Ia. The current atr is 0.05977321.

Antibiotice Ia Daily Average True Range (ATR) ChartAntibiotice Ia Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Antibiotice Ia. The current obv is 2,645,235.

Antibiotice Ia Daily On-Balance Volume (OBV) ChartAntibiotice Ia Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Antibiotice Ia. The current mfi is 21.63.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Antibiotice Ia Daily Money Flow Index (MFI) ChartAntibiotice Ia Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Antibiotice Ia.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Antibiotice Ia Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Antibiotice Ia based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.790
Ma 20Greater thanMa 502.573
Ma 50Greater thanMa 1002.728
Ma 100Greater thanMa 2002.905
OpenGreater thanClose2.560
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Antibiotice with someone you think should read this too:
  • Are you bullish or bearish on Antibiotice? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Antibiotice? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Antibiotice Ia

I send you an email if I find something interesting about Antibiotice Ia.


Comments

How you think about this?

Leave a comment

Stay informed about Antibiotice Ia.

Receive notifications about Antibiotice Ia in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.